3l-Image-Vyvanse - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Vyvanse® (lisdexamfetamine) for the Treatment of Binge-Eating Disorder

3l-Image—Vyvanse
Vyvanse® is a schedule II controlled substance due to the drug abuse risk. Image courtesy of TLVshac.